Form D · Other Health Care
Fresenius Medical Care Newark, LLC
Waltham, MA · CIK 0002079190
Offering snapshot reported Jul 31, 2025 · SEC filing
- Reported sold
- $4.86M Offering amount: $4.86M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $486K Reported outside-investor minimum
- First sale
- Jul 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 31, 2025 | Initial | $4,862,375 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-553360
Managers of Issuer may require Members to make capital contributions from time to time in addition to offering amount listed above, in proportion to Members' respective ownership in Issuer, if Managers determine that Issuer needs additional capital.
Source: Form D, filed Jul 31, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank K. Boateng, M.D. | Director |
| Brad Bucci | Director |
| Trevor Halliday | Director |
| Erik Lyesiuk | Director |
| Jessica Wells | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Fresenius Medical Care North America 920 Winter Street
Waltham, MA, 02451
Waltham, MA, 02451